| Updated prognostic factors in localized NSCLC S Garinet, P Wang, A Mansuet-Lupo, L Fournel, M Wislez, H Blons Cancers 14 (6), 1400, 2022 | 60 | 2022 |
| Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort S Chaibi, J Boussier, W El Hajj, Y Abitbol, S Taieb, C Horaist, ... Clinics and Research in Hepatology and Gastroenterology 45 (5), 101556, 2021 | 35 | 2021 |
| Targeted therapy for older patients with non-small cell lung cancer: Systematic review and guidelines from the French Society of Geriatric Oncology (SoFOG) and the French … L Greillier, M Gauvrit, E Paillaud, N Girard, C Montégut, R Boulahssass, ... Cancers 14 (3), 769, 2022 | 16 | 2022 |
| Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study G Bilger, AC Toffart, M Darrason, M Duruisseaux, L Ulmer, P Wang, ... Therapeutic Advances in Medical Oncology 14, 17588359221099399, 2022 | 8 | 2022 |
| Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study A Saib, W Amara, P Wang, S Cattan, A Dellal, K Regaieg, S Nahon, ... Plos one 16 (6), e0252388, 2021 | 8 | 2021 |
| Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer–Case Report P Wang, L Matton, F Kebir, K Kerrou, A Dubois, R Lacave, J Cadranel, ... Clinical Lung Cancer 23 (8), e568-e572, 2022 | 4 | 2022 |
| Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report P Wang, E Fabre, A Martin, K Chouahnia, A Benabadji, L Matton, ... Frontiers in Oncology 12, 918855, 2022 | 3 | 2022 |
| Incidental diagnosis of lung cancer on chest CT scan performed for suspected or documented COVID-19 infection P Wang, P Martel, M El Hajjam, L Grimaldi, EG Leprieur Respiratory Medicine and Research 85, 101084, 2024 | 2 | 2024 |
| Updated Prognostic Factors in Localized NSCLC. Cancers 2022, 14, 1400 S Garinet, P Wang, A Mansuet-Lupo, L Fournel, M Wislez, H Blons s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | 1 | 2022 |
| Real hypersurfaces in nonflat complex space forms whose h-operator is parallel with respect to the generalized Tanaka-Webster connection Y Wang, P Wang Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales. Serie …, 2024 | | 2024 |
| Un nouveau regard sur la prise en charge des maladies bronchiques obstructives chroniques P Wang, T Soumagne, C Morelot-Panzini, N Roche Revue des Maladies Respiratoires Actualités 16 (1), 1S46-1S51, 2024 | | 2024 |
| Mise en évidence d’une reprogrammation métabolique des neutrophiles circulants chez les patients atteints de cancer bronchique pulmonaire non à petites cellules métastatiques P Wang, P Mouillot, J Swiderski, M Andrieu, S Many, G Birsen, M Wislez, ... Revue des Maladies Respiratoires 41 (3), 196, 2024 | | 2024 |
| Dysrégulation métabolique et fonctionnelle associée à une surexpression de PCNA cytosolique dans les neutrophiles circulants chez les patients atteints de cancer … P Wang, P Mouillot, J Swiderski, M Andrieu, S Many, G Birsen, M Wislez, ... Revue des Maladies Respiratoires Actualités 16 (1), 267-268, 2024 | | 2024 |
| Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer L Belaidi, P Wang, K Quintin, C Durdux, E Giroux-Leprieur, P Giraud Cancers 15 (21), 5127, 2023 | | 2023 |
| Étude DECABROC: DEcouverte fortuite de CAncer BROnchique dans le cadre d’un scanner thoracique réalisé pour infection COVID-19 suspectée ou confirmée P Wang, P Samb, A Rozes, C Saussol, C Poret, R Thirard, M El Hajjam, ... Revue des Maladies Respiratoires Actualités 15 (1), 240, 2023 | | 2023 |
| Dépistage du cancer du poumon: mise au point, actualités et perspectives P Wang, J Chapron, S Bennani, MP Revel, M Wislez Bulletin du Cancer 110 (1), 42-54, 2023 | | 2023 |
| La radiothérapie postopératoire dans les cancers non à petites cellules de stade IIIA–N2: mise au point et perspectives P Wang, B Duchemann, K Chouahnia, L Matton, A Benabadji, L Zelek, ... Bulletin du Cancer 110 (1), 101-112, 2023 | | 2023 |
| Lung cancer screening: Update, news and perspectives P Wang, J Chapron, S Bennani, MP Revel, M Wislez Bulletin du Cancer, S0007-4551 (22) 00427, 2022 | | 2022 |
| Postoperative radiotherapy in non-small cell lung cancer stage IIIA-N2: Focus and perspectives P Wang, B Duchemann, K Chouahnia, L Matton, A Benabadji, L Zelek, ... Bulletin du Cancer, S0007-4551 (22) 00348, 2022 | | 2022 |
| Augmentation des délais de prise charge du cancer du poumon pendant la pandémie COVID-19: expérience d’un centre de diagnostic rapide ambulatoire P Wang, F Millet, A Canelas, V Fallet, T Makaon, D Moal, D Mourlon, ... Revue des Maladies Respiratoires Actualités 14 (1), 58-59, 2022 | | 2022 |
